Skip to main content
PMC home page
Frontiers in Cell and Developmental Biology logoLink to Frontiers in Cell and Developmental Biology
. 2022 Jan 20;10:840894. doi: 10.3389/fcell.2022.840894

Engraftment, Fate, and Function of HoxB8-Conditional Neutrophil Progenitors in the Unconditioned Murine Host

Joshua T Cohen 1,†, Michael Danise 1,†, Kristina D Hinman 1,2, Brittany M Neumann 1, Renita Johnson 1, Zachary S Wilson 1,2, Anna Chorzalska 3, Patrycja M Dubielecka 3, Craig T Lefort 1,*
PMCID: PMC8812959  PMID: 35127689

Abstract

The development and use of murine myeloid progenitor cell lines that are conditionally immortalized through expression of HoxB8 has provided a valuable tool for studies of neutrophil biology. Recent work has extended the utility of HoxB8-conditional progenitors to the in vivo setting via their transplantation into irradiated mice. Here, we describe the isolation of HoxB8-conditional progenitor cell lines that are unique in their ability to engraft in the naïve host in the absence of conditioning of the hematopoietic niche. Our results indicate that HoxB8-conditional progenitors engraft in a β1 integrin-dependent manner and transiently generate donor-derived mature neutrophils. Furthermore, we show that neutrophils derived in vivo from transplanted HoxB8-conditional progenitors are mobilized to the periphery and recruited to sites of inflammation in a manner that depends on the C-X-C chemokine receptor 2 and β2 integrins, the same mechanisms that have been described for recruitment of endogenous primary neutrophils. Together, our studies advance the understanding of HoxB8-conditional neutrophil progenitors and describe an innovative tool that, by virtue of its ability to engraft in the naïve host, will facilitate mechanistic in vivo experimentation on neutrophils.

Keywords: neutrophils, hematopoietic stem and progenitor cell (HSPC), engraftment, granulopoeisis, cell therapeutics, leukocyte recruitment

Introduction

As mediators of the acute inflammatory response, neutrophils play essential roles in host defense against bacterial and fungal infection (Ley et al., 2018). Neutrophil development into their mature effector state primarily occurs in the bone marrow. Neutrophils are abundant and short-lived, a combination that requires the expenditure of a great amount of energy and resources to produce around a billion mature neutrophils per kilogram human body mass per day under homeostasis (Kubes, 2018). The rationale for the host’s investment in the neutrophil is underscored by the manifestation of recurrent and severe infections in individuals with neutropenia or neutrophil dysfunction (Ley et al., 2018).

While primary neutrophils are easily obtained from blood or tissue samples, they are non-proliferative and have a short lifespan. Moreover, common techniques for introducing genetic material to cells result in artefactual activation of primary neutrophils. Thus, even in the current age of facile genetic engineering, mechanistic investigation of neutrophil biology remains a challenge. For decades, neutrophil biologists have relied on imperfect “neutrophil-like” cell lines that fail to fully recapitulate the breadth of neutrophil functionality and may differ from primary neutrophils mechanistically in those functions. Such models include human HL-60 cells (Collins et al., 1978) and murine MPRO (Lawson et al., 1998) and 32D clone 3 (Valtieri et al., 1987) cell lines. The limitations of these neutrophil-like cell models have been comprehensively reviewed (Gupta et al., 2014; Blanter et al., 2021).

More recently, an improved approach was described for deriving neutrophils from murine myeloid progenitors that are conditionally immortalized through controlled expression of HoxB8 (Wang et al., 2006). Expression of HoxB8, a member of the homeobox family of transcription factors, blocks the terminal differentiation of progenitors into monocytes or granulocytes (Krishnaraju et al., 1997; Knoepfler et al., 2001). Neutrophils differentiated in vitro from HoxB8-conditional murine myeloid progenitors have been extensively characterized and have shown much promise in replicating the biological functions displayed ex vivo by isolated murine neutrophils (McDonald et al., 2011; Weiss et al., 2018; Zehrer et al., 2018; Chu et al., 2019; Saul et al., 2019).

Recent studies have further extended the utilization of HoxB8-conditional progenitors as an experimental tool for in vivo studies via their transplantation into mice. Among the wide range of genetic disorders that impact neutrophil development or function, there are more than a dozen different genes whose mutation underlies severe congenital neutropenia as component of the phenotype (Ley et al., 2018). Deficiency of glucose-6-phosphatase-β (G6PC3), an enzyme involved in glucose metabolism, results in neutropenia in humans (Boztug et al., 2009) and mice (Cheung et al., 2007). Utilizing HoxB8-conditional progenitors derived from mice deficient in G6PC3, the neutropenic phenotype was replicated and enabled the investigators to gain mechanistic insight into the role of G6PC3 in neutrophil development (Gautam et al., 2013). In those studies, the HoxB8-conditional progenitor system permitted the exogenous expression of the anti-apoptotic protein Bcl-XL to disentangle the defects in neutrophil progenitor survival from defects in differentiation (Gautam et al., 2013). In another study that employed a mouse model of arthritis, neutrophils derived in vivo from HoxB8-conditional progenitors that were adoptively transferred into conditioned mice could be recruited to the inflamed joint (Orosz et al., 2021). In the absence of endogenous host neutrophils, mice that received HoxB8-conditional progenitors exhibited ankle swelling and a clinical score that mirrored that of control mice with intact endogenous neutrophils (Orosz et al., 2021).

There is accumulating evidence that HoxB8-conditional progenitors could be a tool for neutrophil biologists to perform mechanistic and disease model studies in vivo on primary-like neutrophils. However, the most significant limitation and drawback to the work described above is that in each study recipient mice needed to be conditioned with irradiation to allow repopulation of the hematopoietic compartment with HoxB8-conditional progenitors. Myeloablative conditioning results in irradiation- or chemical-induced toxicity and inflammation that can significantly impact mouse disease models and confound mechanistic studies (Xun et al., 1994; Duran-Struuck and Dysko, 2009). Orosz and others recently demonstrated the absolute requirement for lethally irradiating recipient mice to achieve engraftment of their HoxB8-conditional progenitors (Orosz et al., 2021). Here, we describe the novel discovery of an independently derived HoxB8-conditional progenitor cell line that is able to robustly engraft in naïve recipient mice, in the absence of conditioning the hematopoietic niche. Our results also indicate that neutrophils generated in vivo from transplanted HoxB8-conditional progenitors are functionally equivalent to endogenous primary neutrophils, in terms of their trafficking and effector activities. Together, these results address a key challenge in the field in developing a facile and tractable tool for mechanistic studies of neutrophil biology.

Materials and Methods

HoxB8 Conditionally-Immortalized Progenitors

All three of the independent derivations of HoxB8-conditional progenitor cell lines analyzed were derived using the same protocol. As described previously (Cohen et al., 2021), a lentivirus-based construct with a tamoxifen-inducible Hoxb8 oncogene (Salmanidis et al., 2013) (a gift from Paul Ekert, Murdoch Children’s Research Institute) with either a puromycin or hygromycin resistance cassette was used to stably express HoxB8 in bone marrow hematopoietic stem and progenitor cells (HSPCs) isolated from C57BL/6 J mice using a kit (Stemcell Technologies). HSPCs were cultured with recombinant murine stem cell factor (SCF) and interleukin-3 (IL-3) for 2 days, exactly as described (Wang et al., 2006), and then subjected to spin-infection (2000 RPM, 60 min, 30°C) with lentivirus in a 24-well plate. Cell culture media consisted of Opti-MEM containing GlutaMax (ThermoFisher), 30 μM beta-mercaptoethanol (Sigma-Aldrich), 10% fetal bovine serum (Gemini Bioproducts), penicillin/streptomycin (Gibco), and non-essential amino acids (Gibco). To establish conditionally-immortalized progenitor lines, cells were cultured in media supplemented with 50 ng/ml SCF (BioLegend), 100 nM Z-4-hydroxytamoxifen (Tocris), and either puromycin (Sigma-Aldrich) or hygromycin (Sigma-Aldrich) for up to 2 weeks. In some cases, we used conditioned media from CHO cells that secrete recombinant murine SCF (a gift from Patrice Dubreuil, Centre de Recherche en Cancérologie de Marseille).

Genetic Disruption Using CRISPR/Cas9

To generate gene knockout cell lines, we used pLentiCRISPR v2 vector, a gift from Feng Zhang (Addgene plasmid #52961). The following 20-nucleotide single-guide RNA (sgRNA) targeting sequences were inserted into pLentiCRSIPR v2: CGG​AAG​CGA​GGT​GCA​GAC​CG (Itga4), AGT​GAC​ATA​GAG​AAT​CCC​AG (Itgb1), AAT​GTC​ATC​GCG​GCG​CTC​AC (Cxcr2); Tln1 and Itgb2 targeting have been previously described (Wilson et al., 2017). Lentivirus was produced using a HEK293T Lenti-X cell line (Takara Bio). HoxB8-conditional progenitors were transduced with lentivirus in the presence of 5 μg/ml polybrene (Sigma-Aldrich) in a 24-well plate subjected to centrifugation at 800 x g for 60 min.

Animals and HoxB8-Conditional Progenitor Transplantation

These studies were approved by the Lifespan Animal Welfare Committee (Approval # 5017-19, Office of Laboratory Animal Welfare Assurance #A3922-01) and were conducted in accordance with Public Health Service guidelines for animal care and use. Experiments used 8-14-week old C57BL/6 or CD45.1 (B6. SJL-PtprcaPepcb/BoyJ) mice (The Jackson Laboratory). Water and standard chow were available ad libitum. For cell transplantation, CD45.1 mice were anesthetized with 3% isoflurane and received 1 × 108 (unless otherwise indicated) HoxB8-conditional progenitors via retro-orbital i. v. injection.

Antibodies

Unless otherwise specified, the following antibodies were from BioLegend: anti-Ly6G (1A8), anti-CD45.1 (A20), anti-CD45.2 (104), anti-cKit (ACK2), anti-CXCR4 (FAB21651, R&D Systems), anti-CD11a (M17/4), anti-CD11b (M1/70), anti-CD18 (M18/2), anti-CD29 (HMB1-1), anti-CD49d (R1-2), anti-CD49e (5H10-27), anti-β7 integrin (FIB27), anti-CD44 (IM7), anti-L-selectin (MEL-14), anti-CD16/32 (93), anti-Ly6C (HK1.4), anti-CXCR2 (SA044G4), anti-CD101 (Moushi101, Invitrogen), anti-FcγRIV (9E9), anti-CD162 2PH1, BD Biosciences).

Analyses of Blood and Bone Marrow

At the indicated time after transplantation of HoxB8-conditional progenitors, blood samples were collected by saphenous venipuncture in K3-EDTA tubes (Sarstedt). Blood samples were subjected to erythrocyte lysis with ammonium chloride (BioLegend). For harvesting bone marrow, mice were euthanized and then femurs and tibias were flushed with ice cold PBS containing 5 mM EDTA and 0.5% BSA (PEB buffer) through 70-μm nylon filters. Samples in PEB buffer were labeled with antibodies as indicated, washed extensively with PEB buffer, and then analyzed by flow cytometry using a MACSQuant Analyzer 10. Data analysis was performed using FlowJo software (BD Biosciences).

Mouse Model of Thioglycollate-Induced Peritonitis

On day 7 post-transplant, an initial blood sample was collected from CD45.1 recipient mice. Mice then received intraperitoneal injection of 1 ml 4% thioglycollate broth (Sigma-Aldrich). Approximately 30 min prior to the end point, a “post-thio” blood sample was collected. At 6 h after injection of thioglycollate, mice were euthanized and the peritoneal lavage was collected by flushing the peritoneal cavity with 5 ml ice cold PEB buffer. Blood and peritoneal lavage samples were labeled with antibodies against CD45.1, CD45.2, Ly6G, CD18 and/or CXCR2 as indicated, and then analyzed by flow cytometry as described above.

Phagocytosis Assay

Bone marrow was harvested as described above and split into samples of approximately 2.5 × 105 cells each in Hanks’ balanced salt solution containing Ca2+/Mg2+ (HBSS) and 10% FBS. Some samples were pretreated with 10 μg/ml cytochalasin D prior to adding 10 μg/mL S. aureus bioparticles conjugated with a pHrodo-Green fluorescent probe (ThermoFisher Scientific). After allowing phagocytosis by incubating samples at 37°C for 60 min, cells were washed twice with ice cold PEB buffer. Samples were labeled with antibodies against CD45.2 and Ly6G before analysis by flow cytometry as described above.

S. aureus Intracellular Killing Assay

A GFP-expressing strain of S. aureus, USA300-sGFP (a gift from Alexander Horswill, University of Colorado Denver), was grown overnight in tryptic soy broth, then diluted 1:10 in fresh broth and grown to log phase. After extensive washing in PBS, the colony forming unit (CFU) density of USA300-sGFP was quantified by measuring its optical density at 600 nm (OD600) on a spectrophotometer. Anti-coagulated blood samples from recipient mice were subjected to lysis of erythrocytes with ammonium chloride (BioLegend) and then labeled at room temperature with antibodies against Ly6G and CD45.2. After washing, samples were resuspended in HBSS containing 10% FBS. Vehicle control or USA300-sGFP (6 × 105 CFU/sample) was added to samples and they were incubated at 37°C for 15 min to allow S. aureus uptake. To remove remaining extracellular S. aureus, samples were washed in the presence of 10 μg/mL lysostaphin, pelleted, and resuspended in HBSS containing 10% FBS. A portion of the sample was transferred to ice for analysis by flow cytometry as the initial 0 min time point. The remaining sample was incubated at 37°C, then transferred to ice for analysis by flow cytometry as described above.

Respiratory Burst Assay

Anti-coagulated blood samples from recipient mice were diluted 10-fold in HBSS containing Ca2+/Mg2+. Samples were then loaded for 15 min with 2.5 μg/ml dihydrorhodamine 123 (DHR123; Cayman Chemical), a probe that fluoresces upon exposure to reactive oxygen intermediates. After DHR123 loading, diphenyleneiodonium (DPI; Sigma Aldrich) was added to the appropriate samples at a concentration of 10 μM just prior to stimulation of samples with either heat-killed S. aureus (HKSA) or 100 ng/ml phorbol 12-myristate 13-acetate (PMA; Sigma-Aldrich). Samples were stimulated for either 15 min (PMA) or 30 min (HKSA). At the end of stimulation, samples were centrifuged to pellet cells, subjected to red blood cell lysis as described above, and then stained on ice with antibodies against CD45.2, CD45.1, and Ly6G. Samples were analyzed by flow cytometry as described above.

Statistical Analyses

All statistical analyses were performed using Prism 8 (GraphPad). Data throughout are presented as the group mean and standard deviation. One-way or two-way analysis of variance (ANOVA) was used to compare the differences between group means and post-hoc analysis was performed using a Bonferroni multiple comparison test. A paired or unpaired (as appropriate) Student’s t-test was used for statistical comparisons limited to two groups.

Results

Engraftment of HoxB8-Conditional Progenitors

Since the approach for conditionally immortalizing murine myeloid progenitors by exogenous expression of HoxB8 was initially described (Wang et al., 2006), others have shown that such progenitor cell lines can be transplanted into irradiated recipient mice and subsequently generate mature, terminally differentiated myeloid leukocytes in the in vivo environment (Gautam et al., 2013; Redecke et al., 2013; Orosz et al., 2021). Recently, we reported that a HoxB8-conditional progenitor cell line that we derived is able to produce substantial numbers of donor graft-derived neutrophils in mice that were not subjected to any conditioning of the hematopoietic niche (Cohen et al., 2021). To understand if the engraftment of HoxB8-conditional progenitors in naïve, unconditioned mice was a unique feature of this particular progenitor cell line, we compared its engraftment to two additional and distinct lines of HoxB8-conditional myeloid progenitors using congenic CD45.1 recipient mice. Each of these three cell lines tested were independently generated using the same protocol, by lentiviral delivery of a tamoxifen-inducible Hoxb8 transgene to hematopoietic stem and progenitor cells (HSPCs) isolated from the bone marrow of C57BL/6 J mice (CD45.2+). To determine whether three distinct HoxB8-conditional progenitor lines would home to and take up residence in the bone marrow, we transplanted them separately in CD45.1 mice that had not received any prior conditioning regimen. For two of the independently-established progenitor lines, line 2 (P2) and line 3 (P3), we observed very few donor-derived cells present in the recipient mouse bone marrow at 4 days after transplant (Figure 1A). This was in contrast to the robust engraftment of progenitor line 1 (P1), as measured by the fraction of CD45.2+ cells in bone marrow (among all CD45+ cells) that were derived from transplanted donor progenitors (Figure 1A). These results indicate that HoxB8-conditional progenitor line 1 has a unique capacity for hematopoietic-intact engraftment.

FIGURE 1.

FIGURE 1

Open in a new tab

Quantification of HoxB8-conditional progenitor engraftment in unconditioned mice. (A) CD45.1 mice received transplantation of 1 × 108 progenitors of one of the three indicated HoxB8-conditional progenitor cell lines that were independently established as described in the Methods. The fraction of all CD45+ bone marrow cells that were derived from transplanted HoxB8-conditional progenitors (CD45.2+) in bone marrow of recipient mice at 5 days after transplantation. HoxB8-conditional progenitor line 1, line 2, and line 3 are indicated here as P1, P2, and P3, respectively. Data were analyzed using one-way ANOVA. *p < 0.05. (B) CD45.1 mice received transplantation of 1 × 108 HoxB8-conditional progenitors (line 1) to perform a time course of both the fraction (blue, left y-axis) and absolute number (red, right y-axis) of donor-derived cells in the bone marrow. (C) The donor-derived (CD45.2+) fraction of all mature Ly6Ghigh neutrophils in the bone marrow CD45.1 mice that received varying doses of HoxB8-conditional progenitors, measured at 7 days post-transplant. (D) Evaluation of the maximum fraction of donor-derived (CD45.2+) neutrophils in the peripheral blood of CD45.1 mice that received transplant of 3 × 107 cells of either the parental HoxB8-conditional progenitor cell line 1 or one of the single-cell clones derived from that cell line. Data were analyzed using one-way ANOVA. *p < 0.05, compared to parental line 1.

To further characterize the engraftment of HoxB8-conditional progenitor cell line 1, we used CD45.1 recipient mice and performed a kinetic analysis of donor-derived CD45.2+ cells in the bone marrow. In this experiment, CD45.1 received 1 × 108 HoxB8-conditional progenitors on day 0. The fraction of all bone marrow CD45+ cells that are derived from transplanted donor cells peaks around day 7 after transplant and are nearly undetectable by day 14 (Figure 1B), following kinetics similar to those observed by others in irradiated recipient mice (Orosz et al., 2021). The absolute number of CD45.2+ donor-derived cells in the bone marrow follows a similar trajectory (Figure 1B), suggesting that a relatively small fraction of transplanted HoxB8-conditional progenitors initially engraft and that it is their proliferation within the hematopoietic niche that drives the substantial donor chimerism that develops over the first week following transplant. Furthermore, we observed a dose-dependence between the number of transplanted progenitors and the fraction of neutrophils in the bone marrow and peripheral blood that were donor-derived on day 7 after transplant (Figure 1C). At longer time points of 45 days and 6 months, we did not detect any donor-derived cells in the bone marrow and there was not a detectable long-term impact on the host stem/progenitor cell composition of the bone marrow (Supplementary Figure S1). These data suggest that once exogenous tamoxifen-driven HoxB8 expression is turned off, donor progenitors enter a terminal differentiation program and their existence is then solely determined by the mature neutrophil lifespan.

The derivation of HoxB8-conditional progenitors from bone marrow HSPCs is likely to produce a heterogeneous mix of conditionally-immortalized myeloid progenitor states. To further understand whether the disparate engraftment among the three HoxB8-immortalized cell lines was due to the presence of a subpopulation with an intrinsic ability to engraft in the bone marrow niche, we generated single-cell clones of progenitor line 1 and then analyzed the engraftment of four distinct clonal progenitor lines that were transplanted into naïve CD45.1 recipient mice. We analyzed peripheral blood longitudinally to assess the peak fraction of donor-derived neutrophils in the periphery among the different clonal lines tested, as there was some variability between progenitor clones in their kinetics of engraftment and differentiation. In addition, we utilized a transplantation dose of 3 × 107 HoxB8-conditional progenitors in order to better resolve potential differences between progenitor line 1 and the clonal progenitor lines. Across four different single-cell clones, we observed a range in the peak fraction of peripheral blood neutrophils that were derived from transplanted donor progenitors (Figure 1D). Clones 6 and 25 exhibited a reduced peak frequency of donor-derived neutrophils in the periphery compared to the parental line 1, whereas the donor fraction for clones 2 and 7 was comparable to that of the parental progenitor line 1 (Figure 1D). These data suggest the presence of a subset of highly-engraftable progenitors within the parental HoxB8-conditional progenitor line 1. As these analyses involved serial sampling of the peripheral blood, we accrued a substantial number of data points to be able to assess whether neutrophils generated from transplanted donor progenitors displace those generated via endogenous host granulopoiesis. There was no detectable relationship between the host-derived neutrophil count in the blood and the fraction of all neutrophils that were derived from the donor (Supplementary Figure S1).

To gain insight into potential cell surface receptors that may regulate engraftment or define a subset of highly-engrafting neutrophil progenitors, we performed flow cytometry analyses of HoxB8-conditional progenitor lines and single-cell clones to evaluate expression of cKit; C-X-C chemokine receptor 4 (CXCR4); integrin subunits CD11a, CD11b, and CD29; CD44, L-selectin, CD16/32, CD101, Ly6C, and Ly6G. Most of these receptors and markers exhibited homogeneous expression levels within each line (Supplementary Figure S2) and many had similar expression across the different progenitor cell lines analyzed (Figure 2). All progenitor lines lacked expression of Ly6G and CD101 (Supplementary Figure S2). Notable differences between progenitor lines include higher cKit expression for the poorly engrafting line 2 and disparate expression levels of several receptors/markers (CD11a, CD29) on progenitor line 3 (Figure 2). There was a prominent Ly6Chigh population within line 1, line 3, and all of the clonal progenitor lines derived from progenitor line 1 (Figure 2). Compared to line 1, line 2 had a reduced fraction of Ly6Chigh progenitors while line 3 exhibited a near 100% fraction of the Ly6Chigh population (Figure 2). However, the frequency of the Ly6Chigh subpopulation exhibited no apparent correlation with the intrinsic engraftment capacity of the respective HoxB8-conditional progenitor cell lines. Together, these data suggest that conditional HoxB8 expression in myeloid progenitors may lead to the immortalization of several different types of progenitors.

FIGURE 2.

FIGURE 2

Open in a new tab

Receptor and surface marker expression on HoxB8-conditional progenitors. Flow cytometry analyses was performed to quantify the cell surface expression of the indicated receptors and markers on the three main HoxB8-conditional progenitor cell lines; line 1 (P1), line 2 (P2), line 3 (P3); and the P1-derived single-cell clonal lines designated clone 2 (C2), clone 6 (C6), clone 7 (C7), and clone 25 (C25). Data were analyzed using one-way ANOVA. *p < 0.05, compared to P1.

Mechanisms of HoxB8-Conditional Progenitor Engraftment

Prior to taking up residence in the hematopoietic niche, transplanted HSPCs must first traffic from the circulation to the bone marrow. Broadly, HSCs (hematopoietic stem cells) and HPCs (hematopoietic progenitor cells) transplanted into conditioned recipients undergo engraftment that depends on the integrin VLA-4 (Papayannopoulou et al., 1995; Potocnik et al., 2000; Qian et al., 2007; Rettig et al., 2012). To determine whether VLA-4 plays a role in the engraftment of HoxB8-conditional progenitors, we used CRISPR/Cas9 to generate progenitor cell lines deficient in either Itga4 or Itgb1 that encode the α4 and β1 subunits of VLA-4, respectively (Supplementary Figure S3). Congenic CD45.1 mice received a 1:1 mix of wild-type and either Itga4 −/− or Itgb1 −/− HoxB8-conditional progenitors. At 5 days post-transplant, we measured the relative fraction of wild-type and knockout CD45.2+ donor-derived cells in the bone marrow (Figure 3A). Interestingly, in the respective recipient mice, the abundance of Itga4 −/− donor cells was similar to that of wild-type donor cells (Figure 3A). In contrast, Itgb1 −/− HoxB8-conditional progenitors exhibited a level of engraftment that was significantly less than that of wild-type (Figure 3A). These data indicate that VLA-4 is not essential for the engraftment of HoxB8-conditional progenitors, but that another β1 integrin subtype plays a role in this process. Flow cytometry analyses of the Itga4 −/− progenitor cell line indicated that CD29 (β1 integrin subunit) remains expressed at the cell surface (Supplementary Figure S3), indicating that other β1 integrins are expressed. Wild-type, but not Itgb1 −/− , progenitors expressed CD49e and CD49f that pair with CD29 to form α5β1 and α6β1 integrins, respectively (Supplementary Figure S3). Wild-type, but not Itga4 −/− , progenitors also expressed α4β7 integrins (Supplementary Figure S3).

FIGURE 3.

FIGURE 3

Open in a new tab

HoxB8-conditional progenitor engraftment and in vivo differentiation. (A) Five days after CD45.1 mice received a 1:1 mix of wild-type and the indicated gene-deficient HoxB8-conditional progenitors, the relative frequency of wild-type and gene knockout cells among all donor-derived cells in the bone marrow was measured by flow cytometry. Data are presented as the relative frequency of each gene knockout type relative to its wild-type counter part, and normalized to the wild-type control (set to equal 1.0). Data were analyzed using one-way ANOVA. *p < 0.05, compared to wild-type. (B) Example flow cytometry dotplots showing analyses of whole bone marrow from CD45.1 mice that received transplant of CD45.2+ HoxB8-conditional progenitors. Samples were labeled to determine expression of CD45.1, CD45.2, cKit and Ly6G. Gating for analyzing only donor-derived cells (top) and the subpopulations of donor-derived cells (bottom) in various states of maturity from progenitors/immature neutrophils (cKit+Ly6G−/low) towards terminal neutrophils (cKit−Ly6Ghigh). (C) Characterization and quantification of the in vivo differentiation of engrafted HoxB8-conditional progenitors at day 4 and day 7 after transplantation.

Extravasation of some leukocyte subsets from blood vessels is dependent on β2 integrins and a recent study suggests that β2 integrins contribute to transplanted HSPC homing (Mei et al., 2020). In contrast to our observations of the reduced engraftment of β1 integrin-deficient HoxB8-conditional progenitors, Itgb2 −/− donor progenitors (Supplementary Figure S3) were present in the bone marrow at similar frequencies as wild-type when transplanted at a 1:1 ratio (Figure 3A). Talin binds to the cytosolic tail of all integrin β chains and is required for integrin activation (Kim et al., 2011). Similar to β1 integrin-deficient HoxB8-conditional progenitors, talin knockout (Tln1 −/−) progenitors exhibited significantly reduced engraftment compared to wild-type control (Figure 3A).

If transplanted donor HoxB8-conditional progenitors truly engraft and take up residence in the bone marrow niche, even if that residence is transient, one would expect to observe progenitor cell proliferation and progressive differentiation towards terminal leukocyte states. We have previously shown that cells in the bone marrow derived from transplanted HoxB8-conditional progenitors that were loaded with a cell proliferation dye exhibit a greater than 20-fold dilution of the dye within 3 days, indicating in vivo proliferation of donor progenitors prior to their differentiation (Cohen et al., 2021). Analyses of all donor-derived cells in the bone marrow at days 4 and 7 after transplant indicate that their composition shifts from being split between cKit+Ly6Glow progenitors and cKit−Ly6Ghigh neutrophils at day 4, to predominantly cKit−Ly6Ghigh neutrophils at day 7 (Figures 3B,C). Taken together, these data suggest that HoxB8-conditional progenitors home to the bone marrow and engraft in the hematopoietic niche, where they transiently proliferate and generate large numbers of mature neutrophils.

Trafficking of Neutrophils Derived From Transplanted HoxB8-Conditional Progenitors

Several studies have demonstrated that HoxB8-conditional progenitors can produce mature neutrophils following their transplantation into irradiated mice (Gautam et al., 2013; Redecke et al., 2013; Orosz et al., 2021). To further probe the dynamics of neutrophils generated in vivo from transplanted HoxB8-conditional progenitors, we first performed experiments using a model of sterile peritonitis induced by intraperitoneal injection of thiogylcollate. First, CD45.1 mice received transplantation of wild-type HoxB8-conditional progenitors and given sufficient time to produce robust chimerism in the blood. In response to peritonitis, we observed, as indicated by the similar levels of donor chimerism in the blood (before and after thioglycollate injection) and in the inflamed peritoneal cavity (Figure 4A). These data indicate that donor-derived neutrophils are recruited to a site of inflammation to an equal extent as endogenous host neutrophils.

FIGURE 4.

FIGURE 4

Open in a new tab

Mechanisms underlying mobilization and recruitment of donor-derived neutrophils. Wild-type HoxB8-conditional progenitors, alone (A) or mixed with CXCR2-deficient (B,C) or β2 integrin-deficient HoxB8-conditional progenitors (D), were transplanted into CD45.1 recipient mice. (A, C,D) Mice were subjected to sterile peritonitis induced by thioglycollate. Blood samples (before and after thioglycollate injection) and peritoneal lavage were analyzed for the frequency of donor-derived wild-type and gene knockout neutrophils, as indicated. Data were analyzed using one-way ANOVA with Bonferroni post-hoc test for multiple comparisons. Statistical comparisons were made only between adjacent compartments/time points. *p < 0.05. (B) In mice not subjected to any inflammatory stimulus, bone marrow and blood samples were collected at day 8 post-transplant and analyzed for the frequency of donor-derived wild-type and CXCR2-deficient neutrophils. Data were analyzed using a paired Student’s t-test. *p < 0.05.

Neutrophils mature in the bone marrow and their subsequent mobilization to the peripheral circulation is regulated by C-X-C chemokine receptor 2 (CXCR2) (Eash et al., 2010). To further understand whether neutrophils derived in vivo from transplanted progenitors are mobilized to the periphery and recruited to a site of inflammation via mechanisms that have been described for primary neutrophils, we performed several types of analyses in mice that had received a mix of wild-type and gene knockout donor progenitors. In these studies, CD45.1 mice received both wild-type and Cxcr2 −/− HoxB8-conditional progenitors and we restricted our analyses to CD45.2+Ly6Ghigh donor neutrophils (Supplementary Figure S4), as nearly 100% of wild-type neutrophils (both host- and donor-derived) express CXCR2 (Supplementary Figure S5). At day 8 post-transplant, donor neutrophils of both genotypes were present in the bone marrow and peripheral blood of recipient mice. However, there was a significant reduction in the relative fraction of those donor neutrophils that were Cxcr2 −/− in the blood compared to the bone marrow (Figure 4B). These data indicate that homeostatic egress of mature donor-derived neutrophils to the periphery is regulated by CXCR2 in a similar manner to that of primary endogenous neutrophils (Eash et al., 2010).

To evaluate the role of CXCR2 in the mobilization of donor neutrophils in response to inflammatory stimuli, we analyzed the cellular composition of peripheral blood before and after mice received intraperitoneal thioglycollate to induce a sterile peritonitis. Similar to the analyses of homeostatic neutrophil egress to the periphery, the CD45.1 mice first received a transplant of a mix of CD45.2-expressing wild-type and Cxcr2 −/− HoxB8-conditional progenitors. The mix of donor progenitors for transplantation was composed of approximately one-third wild-type and two-thirds Cxcr2 −/− progenitors, as we wanted to be able to detect changes in donor neutrophil fraction with the expectation that CXCR2 is involved both in neutrophil mobilization and recruitment, as is known for primary murine neutrophils (Cacalano et al., 1994; Eash et al., 2010). At 90 min after inducing inflammation, there was a significant decrease in the fraction of donor-derived CXCR2-deficient neutrophils in the blood (Figure 4C), indicating a CXCR2-dependent mobilization of donor neutrophils from the bone marrow. There was a further reduction in the fraction of donor-derived Cxcr2 −/− neutrophils relative to wild-type in the peritoneal lavage, relative to the blood (Figure 4C). Taken together, these data confirm that both the stimulated mobilization and recruitment of neutrophils generated in vivo from transplanted HoxB8-conditional progenitors occurs via CXCR2-dependent mechanisms.

Endogenous host neutrophils and those derived in vivo from transplanted donor HoxB8-conditional progenitors express similar levels of adhesion and signaling receptors involved in regulating neutrophil recruitment, including PSGL-1, L-selectin, CD11a, CD11b, CXCR2, and FcγRIV (Supplementary Figure S5). These data are consistent with a recent study, with the exception that we observed equal expression of CD11b and FcγRIV on donor and host neutrophils (Supplementary Figure S5), whereas those receptors were elevated on neutrophils when produced in irradiated recipient mice (Orosz et al., 2021). Two of the major types of β2 integrins expressed by neutrophils, LFA-1 (αLβ2) and Mac-1 (αMβ2), play key roles in neutrophil recruitment by mediating adhesion to inflamed endothelium (Ley et al., 2007). To understand whether donor-derived neutrophils are recruited to sites of inflammation via adhesion mechanisms that have been well described for host-derived primary murine neutrophils, we again used a model of thioglycollate-induced peritonitis in mice that received a 1:1 mix of wild-type and β2 integrin-deficient (Itgb2 −/−) HoxB8-conditional progenitors. While there was a similar proportion of wild-type and Itgb2 −/− donor neutrophils in the blood both before and after inducing inflammation, we observed a significant decrease in the fraction of β2 integrin-deficient donor-derived neutrophils in the peritoneal lavage (Figure 4D). These data indicate that, like primary host neutrophils, neutrophils derived in vivo from transplanted HoxB8-conditional progenitors are recruited to the inflamed peritoneum via β2 integrin-dependent mechanisms.

Effector Functions of Donor Neutrophils Derived in vivo

Previous studies have characterized the effector functions of mature neutrophils derived in vitro and in vivo from HoxB8-conditional progenitors (McDonald et al., 2011; Weiss et al., 2018; Zehrer et al., 2018; Chu et al., 2019; Saul et al., 2019; Orosz et al., 2021). Some of these studies are limited to evaluating only the function of neutrophils derived from HoxB8-conditional progenitors in vitro or lack a controlled in vivo comparison with endogenous host primary neutrophils. Since the unique line of HoxB8-conditional progenitors that we describe in this study engrafts in unconditioned mice, we were therefore able to directly assay both host and donor neutrophil functions under internally controlled conditions. Using CD45.1 mice that received CD45.2+ donor progenitors, we assayed neutrophil effector functions using blood samples. First, we exposed blood samples to Staphylococcus aureus bioparticles conjugated to a pHrodo-Green dye that fluoresces upon internalization into the neutrophil phagolysosome, using a low particle:cell ratio so as to better resolve potential differences between host- and donor-derived neutrophils (Supplementary Figure S6). We observed that neutrophils derived in vivo from transplanted HoxB8-conditional progenitors had a similar capacity for S. aureus bioparticle phagocytosis that was inhibited by the actin-disrupting agent cytochalasin D (Figure 5A).

FIGURE 5.

FIGURE 5

Open in a new tab

Effector function of neutrophils derived in vivo from HoxB8-conditional progenitors. Seven days after CD45.1 mice received transplant of wild-type HoxB8-conditional progenitors, blood samples were subjected to assays of neutrophil function using flow cytometry. CD45.2+Ly6G+ donor-derived neutrophils were distinguished from CD45.1+Ly6G+ host-derived neutrophils for comparative analyses. (A) Host and donor neutrophil phagocytosis of pHrodo-Green conjugated S. aureus, measured after 60 min exposure in the absence or presence of 10 μg/ml cytochalasin D (CD). Data were analyzed using two-way ANOVA with Bonferroni post-hoc test for multiple comparisons. *p < 0.05, compared to 0 min #p < 0.05, compared to 60 min. (B) Host and donor neutrophil intracellular killing of S. aureus, as measured by the fraction of neutrophils remaining GFP+ 45 min after allowing initial phagocytosis of strain USA300-sGFP. The killing efficiency was calculated by comparing the end point fraction of GFP+ neutrophils to the starting point (0 min). Data were analyzed using two-way ANOVA with Bonferroni post-hoc test for multiple comparisons. *p < 0.05, compared to 0 min #p < 0.05, as indicated. Killing efficiency data were analyzed by an unpaired Student’s t-test. (C) Quantification of stimulated ROS generation by host and donor neutrophils, expressed as the mean fluorescence intensity of DHR123. Blood samples were stimulated with either heat-killed S. aureus (HKSA) or 100 ng/ml PMA, in the absence or presence of 10 μM DPI. Data were analyzed using two-way ANOVA with Bonferroni post-hoc test for multiple comparisons. *p < 0.05, compared to unstimulated. #p < 0.05, compared to HKSA or PMA alone.

To determine whether neutrophils are able to kill S. aureus after uptake, we employed an assay based upon the intracellular killing event being shown to result in the bleaching of GFP expressed by a strain of S. aureus (Schwartz et al., 2009). Donor-derived blood neutrophils were able to eradicate live S. aureus to a similar extent as host-derived neutrophils (Figure 5B). Neutrophil intracellular killing of S. aureus occurs in a manner dependent on the NADPH oxidase (NOX2). Both host- and donor-derived neutrophils underwent NOX2-mediated respiratory burst in response to heat-killed S. aureus or PMA, and sensitive to the NOX2 inhibitor DPI (Figure 5C). Together, these data indicate that neutrophils generated from HoxB8-conditional progenitors following their transplantation into naïve mice have competent host defense effector functions.

Discussion

Neutrophils are essential players in the acute inflammatory response. In recent years, investigators have continued to identify novel and diverse roles for neutrophils in many facets of host defense and immune regulation (Kubes, 2018). While neutrophil biologists have long faced experimental limitations and challenges, the emergence of the HoxB8-conditional progenitor system has provided a means for researchers to obtain near-primary neutrophils that are genetically tractable prior to their differentiation. Here, we report the discovery of a unique derivation of a HoxB8-conditional progenitor cell line that is capable of engrafting in naïve mice and results in robust donor neutrophil chimerism that lasts for more than a week.

Hematopoietic stem cell transplantation (HSCT) can be curative for blood cell disorders and malignancies. HSPCs reside in specialized niches within the extravascular space of the bone marrow. For HSCT to be successful, transplanted HSPCs must traffic to these specialized hematopoietic niches and then take up residence through a process called engraftment. It remains a topic of debate whether the engraftment of transplanted HSPCs is limited by the occupancy of specialized niches by host HSPCs (Bhattacharya et al., 2008). Clinically, HSCT recipients undergo irradiation- and/or chemical-induced ablation of the hematopoietic system prior to the injection of HSCs or whole bone marrow. This conditioning of the host promotes donor engraftment through a combination of blocking rejection of the graft by the host immune response and freeing up hematopoietic niche space for donor HSPCs. In the absence of conditioning, while HSC engraftment remains poor even in recipients that are incapable of graft rejection (Muller et al., 2000; Czechowicz et al., 2007; Bhattacharya et al., 2008), the availability of niches for specific subsets of multipotent and lineage-restricted progenitors has not been extensively investigated. However, our derivation of a HoxB8-conditional progenitor cell line that efficiently engrafts in unconditioned mice appears to be a novel discovery, as we found that other independently generated HoxB8-conditional progenitor lines did not engraft and others have demonstrated the absolute requirement for irradiating recipient mice in order to achieve engraftment and donor neutrophil chimerism (Orosz et al., 2021).

Similar to the investigation of HSPCs and conditioning the hematopoietic niche, the mechanisms of HSC homing and engraftment are more clearly defined than those of progenitor subsets with restricted multipotency. The integrin VLA-4 (α4β1) is essential for the homing of transplanted HSCs to the bone marrow (Papayannopoulou et al., 1995; Potocnik et al., 2000; Qian et al., 2007; Rettig et al., 2012). We were therefore surprised to observe that Itga4 −/− HoxB8-conditional progenitors lacking VLA-4 expression engrafted and proliferated in the bone marrow of recipient mice as well as wild-type progenitors. By contrast, β1 integrin-deficient HoxB8-conditional progenitors have impaired homing and/or engraftment, suggesting that a β1 integrin subtype other than VLA-4 plays a role in this process. Furthermore, since talin knockout HoxB8-conditional progenitors were also reduced in their bone marrow frequency relative to wild-type, it would suggest a homing mechanism that involves activated β1 integrins, similar to that observed for β2 integrins and neutrophil trafficking (Lefort et al., 2012). Further investigation of the mechanisms of engraftment for HoxB8-conditional progenitors will also provide insight as to how this cell line is uniquely able to engraft in the absence of myeloablation.

In recent studies, single-cell technologies have enabled the identification of the various neutrophil precursor states that define the maturation process following lineage commitment (Evrard et al., 2018; Zhu et al., 2018; Kwok et al., 2020). Our analyses of cell surface receptors and markers reveal that the progenitor identity that is conditionally immortalized through enforced HoxB8 expression appears to vary between several independent derivations, despite following the same protocol. HoxB8-conditional progenitor line 1 that we describe in this study may be best characterized as a granulocyte macrophage progenitor (GMP), given the bifurcated expression of Ly6C by the parental progenitor line 1 and single-cell clones derived from it, a pattern that exists within GMPs and may be related to lineage commitment decisions (Kwok et al., 2020). Comparing the timing of in vivo differentiation in our studies and those recently reported for neutrophil-committed preNeus (Evrard et al., 2018), the HoxB8-conditional progenitor lines we characterize are unlikely to be in the preNeu stage while HoxB8 is expressed since we did not observe a substantial shift towards cKit−Ly6Ghigh donor cells in the bone marrow until day 4 and later. Future systematic analyses are necessary to understand the divergent outcomes of HoxB8-dependent progenitor immortalization with respect to their developmental identity and eventual engraftment potential as an established cell line.

Our studies confirm that neutrophils derived in vivo from donor progenitors are biologically comparable to endogenous neutrophils, building upon the results of others that have utilized transplantation of HoxB8-conditional progenitors into mice (Gautam et al., 2013; Orosz et al., 2021). In order to show this more definitively, the experiments described here are, to our knowledge, the first to extensively probe the molecular mechanisms of trafficking and function of neutrophils generated in vivo from transplanted HoxB8-conditional progenitors. From CXCR2-dependent mobilization from the bone marrow to neutrophil recruitment mediated by CXCR2 and β2 integrins, we demonstrate that donor-derived neutrophils are functionally equivalent to endogenous host neutrophils. We found that HoxB8-conditional progenitor differentiation that occurs in vivo in the microenvironment of the bone marrow allows donor neutrophils to reach their full functional competence. This contrasts with certain neutrophil functions observed with in vitro differentiation of HoxB8-conditional progenitors, under conditions that are unlikely to fully recapitulate the environment in which neutrophil maturation occurs in the bone marrow. For example, NOX2-dependent stimulated generation of ROS is more than an order of magnitude lower for in vitro-differentiated neutrophils compared to primary neutrophils (Saul et al., 2019). Our results show that ROS generation in response to either S. aureus bioparticles or PMA is no different between endogenous host neutrophils and those derived in vivo from transplanted HoxB8-conditional progenitors. In addition, intracellular eradication of S. aureus occurs as well in donor-derived neutrophils as in host-derived neutrophils. Taken together, our results strongly suggest that mature neutrophils that are generated in mice from adoptively transplanted HoxB8-conditional progenitors are biologically equivalent to primary neutrophils.

Multidrug-resistant (MDR) bacterial and fungal infections are an increasingly urgent clinical challenge, especially for opportunistic pathogens that cause severe disease in the immunocompromised. Due to a number of factors, the pipeline for new antibiotics has seen a drastic reduction in productivity (Lewis, 2013). Immunomodulatory and cell therapeutic strategies are being pursued as a complementary approach or alternative to antibiotics (Hancock et al., 2012; Kumaresan et al., 2014). While granulocyte transfusion therapy has experienced a long and detoured path in clinical implementation (Marfin and Price, 2015), it may be worth revisiting its conceptual basis as new approaches are developed for generating neutrophils (both ex vivo and in vivo). We posit that conditionally-immortalized neutrophil progenitors could be an effective cellular therapeutic in the context of neutropenia or a dysregulated inflammatory response. Given their genetic tractability, murine HoxB8-conditional progenitors represent an innovative system for investigating means to enhance neutrophil effector functions. In this way, an off-the-shelf product that transiently generates neutrophils with superior capacity to, for example, overcome evasive intracellular survival of MDR S. aureus (Greenlee-Wacker et al., 2015) may be an option alongside antibiotics of last resort.

There remain some limitations to the study reported here. The technical aspects in deriving HoxB8-conditional progenitors that lead to cell lines with high engraftment capacity in unconditioned mice, as compared those that lack engraftment capacity that have been demonstrated here and by others (Orosz et al., 2021), remain unclear and should be the subject of future studies. We posit that the timing of HoxB8 induction in HSPCs relative to their isolation may influence the progenitor type that is conditionally-immortalized. For our experiments, recipient mice exhibited donor neutrophil chimerism in the periphery that took 4 days to reached levels above 10%, suggesting limitations to the potential therapeutic applications of neutrophil progenitors. Further investigation into modulating the kinetics of in vivo proliferation and/or differentiation may broaden the translational impact in this new area of cell therapies to augment host defense. Future studies are also needed to understand whether neutrophils generated in vivo from transplanted progenitors exhibit subsets with transcriptional heterogeneity, as has been described for endogenous bone marrow and blood neutrophils in the mouse (Xie et al., 2020).

In conclusion, our studies describe a new HoxB8-conditional progenitor cell line that is uniquely capable of transient engraftment in the unconditioned murine host in a manner that depends on β1 integrins, but not VLA-4. Within the bone marrow, transplanted HoxB8-conditional progenitors proliferate and differentiate into mature neutrophils that are mechanistically and functionally the equivalent of primary neutrophils. These results further confirm the utility of the HoxB8 progenitor system for experimental neutrophil biology and suggest future translational avenues.

Acknowledgments

We thank Dr. Paul Ekert, Dr. Patrice Dubreuil, and Dr. Alexander Horswill for kindly providing reagents/resources.

Data Availability Statement

The raw data supporting the conclusion of this article will be made available by the authors, without undue reservation.

Ethics Statement

The animal study was reviewed and approved by Lifespan Animal Welfare Committee, Rhode Island Hospital.

Author Contributions

JC: Developing cell lines, designing research studies, conducting experiments, analyzing data. MD: Developing cell lines, designing research studies, conducting experiments, analyzing data. KH: Designing research studies, conducting experiments, analyzing data. BN: Designing research studies, conducting experiments, analyzing data. RJ: Designing research studies, conducting experiments. ZW: Developing cell lines. AC: Designing research studies, analyzing data. PD: Designing research studies. CL: Supervising the project, designing research studies, conducting experiments, analyzing data, writing the manuscript.

Funding

This research was supported by awards from the National Institutes of Health (GM124911 to CL; GM119943 and CA218079 to PD; T32GM065085 supported JC; and T32HL134625 supported BN), Brown Physicians, Inc. (CL), and the Armand D. Versaci Research Scholarship in Surgical Sciences (MD).

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors, and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary Material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fcell.2022.840894/full#supplementary-material

Click here for additional data file. (808.2KB, PDF)

References

  1. Bhattacharya D., Ehrlich L. I. R., Weissman I. L. (2008). Space-time Considerations for Hematopoietic Stem Cell Transplantation. Eur. J. Immunol. 38 (8), 2060–2067. 10.1002/eji.200838383 [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Blanter M., Gouwy M., Struyf S. (2021). Studying Neutrophil Function In Vitro: Cell Models and Environmental Factors. Jir 14, 141–162. 10.2147/JIR.S284941 [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Boztug K., Appaswamy G., Ashikov A., Schäffer A. A., Salzer U., Diestelhorst J., et al. (2009). A Syndrome with Congenital Neutropenia and Mutations inG6PC3. N. Engl. J. Med. 360 (1), 32–43. 10.1056/NEJMoa0805051 [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cacalano G., Lee J., Kikly K., Ryan A. M., Pitts-Meek S., Hultgren B., et al. (1994). Neutrophil and B Cell Expansion in Mice that Lack the Murine IL-8 Receptor Homolog. Science 265 (5172), 682–684. 10.1126/science.8036519 [DOI] [PubMed] [Google Scholar]
  5. Cheung Y. Y., Kim S. Y., Yiu W. H., Pan C.-J., Jun H.-S., Ruef R. A., et al. (2007). Impaired Neutrophil Activity and Increased Susceptibility to Bacterial Infection in Mice Lacking Glucose-6-Phosphatase-β. J. Clin. Invest. 117 (3), 784–793. 10.1172/JCI30443 [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chu J. Y., McCormick B., Mazelyte G., Michael M., Vermeren S. (2019). HoxB8 Neutrophils Replicate Fcγ Receptor and Integrin‐induced Neutrophil Signaling and Functions. J. Leukoc. Biol. 105 (1), 93–100. 10.1002/JLB.1AB0618-232R [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cohen J. T., Danise M., Machan J. T., Zhao R., Lefort C. T. (2021). Murine Myeloid Progenitors Attenuate Immune Dysfunction Induced by Hemorrhagic Shock. Stem Cel Rep. 16 (2), 324–336. 10.1016/j.stemcr.2020.12.014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Collins S. J., Ruscetti F. W., Gallagher R. E., Gallo R. C. (1978). Terminal Differentiation of Human Promyelocytic Leukemia Cells Induced by Dimethyl Sulfoxide and Other Polar Compounds. Proc. Natl. Acad. Sci. 75 (5), 2458–2462. 10.1073/pnas.75.5.2458 [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Czechowicz A., Kraft D., Weissman I. L., Bhattacharya D. (2007). Efficient Transplantation via Antibody-Based Clearance of Hematopoietic Stem Cell Niches. Science 318 (5854), 1296–1299. 10.1126/science.1149726 [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Duran-Struuck R., Dysko R. C. (2009). Principles of Bone Marrow Transplantation (BMT): Providing Optimal Veterinary and Husbandry Care to Irradiated Mice in BMT Studies. J. Am. Assoc. Lab. Anim. Sci. 48 (1), 11–22. [PMC free article] [PubMed] [Google Scholar]
  11. Eash K. J., Greenbaum A. M., Gopalan P. K., Link D. C. (2010). CXCR2 and CXCR4 Antagonistically Regulate Neutrophil Trafficking from Murine Bone Marrow. J. Clin. Invest. 120 (7), 2423–2431. 10.1172/JCI41649 [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Evrard M., Kwok I. W. H., Chong S. Z., Teng K. W. W., Becht E., Chen J., et al. (2018). Developmental Analysis of Bone Marrow Neutrophils Reveals Populations Specialized in Expansion, Trafficking, and Effector Functions. Immunity 48 (2), 364–379. 10.1016/j.immuni.2018.02.002 [DOI] [PubMed] [Google Scholar]
  13. Gautam S., Kirschnek S., Gentle I. E., Kopiniok C., Henneke P., Häcker H., et al. (2013). Survival and Differentiation Defects Contribute to Neutropenia in Glucose-6-Phosphatase-β (G6PC3) Deficiency in a Model of Mouse Neutrophil Granulocyte Differentiation. Cell Death Differ 20 (8), 1068–1079. 10.1038/cdd.2013.39 [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Greenlee-Wacker M., DeLeo F. R., Nauseef W. M. (2015). How Methicillin-Resistant Staphylococcus aureus Evade Neutrophil Killing. Curr. Opin. Hematol. 22 (1), 30–35. 10.1097/MOH.0000000000000096 [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gupta D., Shah H. P., Malu K., Berliner N., Gaines P. (2014). Differentiation and Characterization of Myeloid Cells. Curr. Protoc. Immunol. 104, Unit 22F 25. 10.1002/0471142735.im22f05s104 [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hancock R. E. W., Nijnik A., Philpott D. J. (2012). Modulating Immunity as a Therapy for Bacterial Infections. Nat. Rev. Microbiol. 10 (4), 243–254. 10.1038/nrmicro2745 [DOI] [PubMed] [Google Scholar]
  17. Kim C., Ye F., Ginsberg M. H. (2011). Regulation of Integrin Activation. Annu. Rev. Cel Dev. Biol. 27, 321–345. 10.1146/annurev-cellbio-100109-104104 [DOI] [PubMed] [Google Scholar]
  18. Knoepfler P. S., Sykes D. B., Pasillas M., Kamps M. P. (2001). HoxB8 Requires its Pbx-Interaction Motif to Block Differentiation of Primary Myeloid Progenitors and of Most Cell Line Models of Myeloid Differentiation. Oncogene 20 (39), 5440–5448. 10.1038/sj.onc.1204710 [DOI] [PubMed] [Google Scholar]
  19. Krishnaraju K., Hoffman B., Liebermann D. A. (1997). Lineage-specific Regulation of Hematopoiesis by HOX-B8 (HOX-2.4): Inhibition of Granulocytic Differentiation and Potentiation of Monocytic Differentiation. Blood 90 (5), 1840–1849. 10.1182/blood.v90.5.1840 [DOI] [PubMed] [Google Scholar]
  20. Kubes P. (2018). The Enigmatic Neutrophil: what We Do Not Know. Cell Tissue Res 371 (3), 399–406. 10.1007/s00441-018-2790-5 [DOI] [PubMed] [Google Scholar]
  21. Kumaresan P. R., Manuri P. R., Albert N. D., Maiti S., Singh H., Mi T., et al. (2014). Bioengineering T Cells to Target Carbohydrate to Treat Opportunistic Fungal Infection. Proc. Natl. Acad. Sci. 111 (29), 10660–10665. 10.1073/pnas.1312789111 [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Kwok I., Becht E., Xia Y., Ng M., Teh Y. C., Tan L., et al. (2020). Combinatorial Single-Cell Analyses of Granulocyte-Monocyte Progenitor Heterogeneity Reveals an Early Uni-Potent Neutrophil Progenitor. Immunity 53 (2), 303–318. 10.1016/j.immuni.2020.06.005 [DOI] [PubMed] [Google Scholar]
  23. Lawson N. D., Krause D. S., Berliner N. (1998). Normal Neutrophil Differentiation and Secondary Granule Gene Expression in the EML and MPRO Cell Lines. Exp. Hematol. 26 (12), 1178–1185. [PubMed] [Google Scholar]
  24. Lefort C. T., Rossaint J., Moser M., Petrich B. G., Zarbock A., Monkley S. J., et al. (2012). Distinct Roles for Talin-1 and Kindlin-3 in LFA-1 Extension and Affinity Regulation. Blood 119 (18), 4275–4282. 10.1182/blood-2011-08-373118 [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Lewis K. (2013). Platforms for Antibiotic Discovery. Nat. Rev. Drug Discov. 12 (5), 371–387. 10.1038/nrd3975 [DOI] [PubMed] [Google Scholar]
  26. Ley K., Hoffman H. M., Kubes P., Cassatella M. A., Zychlinsky A., Hedrick C. C., et al. (2018). Neutrophils: New Insights and Open Questions. Sci. Immunol. 3 (30). 10.1126/sciimmunol.aat4579 [DOI] [PubMed] [Google Scholar]
  27. Ley K., Laudanna C., Cybulsky M. I., Nourshargh S. (2007). Getting to the Site of Inflammation: the Leukocyte Adhesion cascade Updated. Nat. Rev. Immunol. 7 (9), 678–689. 10.1038/nri2156 [DOI] [PubMed] [Google Scholar]
  28. Marfin A. A., Price T. H. (2015). Granulocyte Transfusion Therapy. J. Intensive Care Med. 30 (2), 79–88. 10.1177/0885066613498045 [DOI] [PubMed] [Google Scholar]
  29. McDonald J. U., Cortini A., Rosas M., Fossati‐Jimack L., Ling G. S., Lewis K. J., et al. (2011). In Vivo functional Analysis and Genetic Modification of In Vitro ‐derived Mouse Neutrophils. FASEB j. 25 (6), 1972–1982. 10.1096/fj.10-178517 [DOI] [PubMed] [Google Scholar]
  30. Mei Y., Han X., Liu Y., Yang J., Sumagin R., Ji P. (2020). Diaphanous-related Formin mDia2 Regulates Beta2 Integrins to Control Hematopoietic Stem and Progenitor Cell Engraftment. Nat. Commun. 11 (1), 3172. 10.1038/s41467-020-16911-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Müller S. M., Kohn T., Schulz A. S., Debatin K. M., Friedrich W. (2000). Similar Pattern of Thymic-dependent T-Cell Reconstitution in Infants with Severe Combined Immunodeficiency after Human Leukocyte Antigen (HLA)-identical and HLA-Nonidentical Stem Cell Transplantation. Blood 96 (13), 4344–4349. [PubMed] [Google Scholar]
  32. Orosz A., Walzog B., Mócsai A. (2021). In Vivo Functions of Mouse Neutrophils Derived from HoxB8-Transduced Conditionally Immortalized Myeloid Progenitors. J.I. 206 (2), 432–445. 10.4049/jimmunol.2000807 [DOI] [PubMed] [Google Scholar]
  33. Papayannopoulou T., Craddock C., Nakamoto B., Priestley G. V., Wolf N. S. (1995). The VLA4/VCAM-1 Adhesion Pathway Defines Contrasting Mechanisms of Lodgement of Transplanted Murine Hemopoietic Progenitors between Bone Marrow and Spleen. Proc. Natl. Acad. Sci. 92 (21), 9647–9651. 10.1073/pnas.92.21.9647 [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Potocnik A. J., Brakebusch C., Fässler R. (2000). Fetal and Adult Hematopoietic Stem Cells Require β1 Integrin Function for Colonizing Fetal Liver, Spleen, and Bone Marrow. Immunity 12 (6), 653–663. 10.1016/s1074-7613(00)80216-2 [DOI] [PubMed] [Google Scholar]
  35. Qian H., Georges-Labouesse E., Nyström A., Domogatskaya A., Tryggvason K., Jacobsen S. E. W., et al. (2007). Distinct Roles of Integrins α6 and α4 in Homing of Fetal Liver Hematopoietic Stem and Progenitor Cells. Blood 110 (7), 2399–2407. 10.1182/blood-2006-10-051276 [DOI] [PubMed] [Google Scholar]
  36. Redecke V., Wu R., Zhou J., Finkelstein D., Chaturvedi V., High A. A., et al. (2013). Hematopoietic Progenitor Cell Lines with Myeloid and Lymphoid Potential. Nat. Methods 10 (8), 795–803. 10.1038/nmeth.2510 [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Rettig M. P., Ansstas G., DiPersio J. F. (2012). Mobilization of Hematopoietic Stem and Progenitor Cells Using Inhibitors of CXCR4 and VLA-4. Leukemia 26 (1), 34–53. 10.1038/leu.2011.197 [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Salmanidis M., Brumatti G., Narayan N., Green B. D., van den Bergen J. A., Sandow J. J., et al. (2013). Hoxb8 Regulates Expression of microRNAs to Control Cell Death and Differentiation. Cel Death Differ 20 (10), 1370–1380. 10.1038/cdd.2013.92 [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Saul S., Castelbou C., Fickentscher C., Demaurex N. (2019). Signaling and Functional Competency of Neutrophils Derived from Bone‐marrow Cells Expressing the ER‐HOXB8 Oncoprotein. J. Leukoc. Biol. 106 (5), 1101–1115. 10.1002/JLB.2A0818-314R [DOI] [PubMed] [Google Scholar]
  40. Schwartz J., Leidal K. G., Femling J. K., Weiss J. P., Nauseef W. M. (2009). Neutrophil Bleaching of GFP-Expressing Staphylococci: Probing the Intraphagosomal Fate of Individual Bacteria. J. Immunol. 183 (4), 2632–2641. 10.4049/jimmunol.0804110 [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Valtieri M., Tweardy D. J., Caracciolo D., Johnson K., Mavilio F., Altmann S., et al. (1987). Cytokine-dependent Granulocytic Differentiation. Regulation of Proliferative and Differentiative Responses in a Murine Progenitor Cell Line. J. Immunol. 138 (11), 3829–3835. [PubMed] [Google Scholar]
  42. Wang G. G., Calvo K. R., Pasillas M. P., Sykes D. B., Häcker H., Kamps M. P. (2006). Quantitative Production of Macrophages or Neutrophils Ex Vivo Using Conditional Hoxb8. Nat. Methods 3 (4), 287–293. 10.1038/nmeth865 [DOI] [PubMed] [Google Scholar]
  43. Weiss E., Hanzelmann D., Fehlhaber B., Klos A., Loewenich F. D., Liese J., et al. (2018). Formyl‐peptide Receptor 2 Governs Leukocyte Influx in Local Staphylococcus aureus Infections. FASEB j. 32 (1), 26–36. 10.1096/fj.201700441R [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Wilson Z. S., Ahn L. B., Serratelli W. S., Belley M. D., Lomas-Neira J., Sen M., et al. (2017). Activated β2Integrins Restrict Neutrophil Recruitment during Murine Acute Pseudomonal Pneumonia. Am. J. Respir. Cel Mol Biol 56 (5), 620–627. 10.1165/rcmb.2016-0215OC [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Xie X., Shi Q., Wu P., Zhang X., Kambara H., Su J., et al. (2020). Single-cell Transcriptome Profiling Reveals Neutrophil Heterogeneity in Homeostasis and Infection. Nat. Immunol. 21 (9), 1119–1133. 10.1038/s41590-020-0736-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Xun C., Thompson J., Jennings C., Brown S., Widmer M. (1994). Effect of Total Body Irradiation, Busulfan-Cyclophosphamide, or Cyclophosphamide Conditioning on Inflammatory Cytokine Release and Development of Acute and Chronic Graft-Versus-Host Disease in H-2- Incompatible Transplanted SCID Mice. Blood 83 (8), 2360–2367. 10.1182/blood.v83.8.2360.bloodjournal8382360 [DOI] [PubMed] [Google Scholar]
  47. Zehrer A., Pick R., Salvermoser M., Boda A., Miller M., Stark K., et al. (2018). A Fundamental Role of Myh9 for Neutrophil Migration in Innate Immunity. J.I. 201 (6), 1748–1764. 10.4049/jimmunol.1701400 [DOI] [PubMed] [Google Scholar]
  48. Zhu Y. P., Padgett L., Dinh H. Q., Marcovecchio P., Blatchley A., Wu R., et al. (2018). Identification of an Early Unipotent Neutrophil Progenitor with Pro-tumoral Activity in Mouse and Human Bone Marrow. Cel Rep. 24 (9), 2329–2341. 10.1016/j.celrep.2018.07.097 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Click here for additional data file. (808.2KB, PDF)

Data Availability Statement

The raw data supporting the conclusion of this article will be made available by the authors, without undue reservation.

Articles from Frontiers in Cell and Developmental Biology are provided here courtesy of Frontiers Media SA

RESOURCES